Ignite Creation Date:
2024-05-06 @ 3:02 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04501718
Status:
RECRUITING
Last Update Posted:
2023-04-19
First Post:
2020-08-04
Brief Title:
Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Sponsor:
Beijing Sanbo Brain Hospital
Organization:
Beijing Sanbo Brain Hospital
Organization Data
Organization:
Beijing Sanbo Brain Hospital
Class:
OTHER
Study ID:
OBU-BJ-MB-II-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Sanbo Brain Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Junping Zhang
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Sanbo Brain Hospital
Old Name:
None
Old Organization:
None